Related Experiment Video
Updated: May 17, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
[Percutaneous treatment of valvular heart diseases]
Federica Ettori1, Claudia Fiorina, Felicia Lipartiti
1U.O. Cardiologia, Dipartimento Cardiotoracico, Spedali Civili, Brescia.
Abstract:
Surgical valve replacement represents the treatment of choice for symptomatic and severe valvular heart disease. However, the operative risk is increased in presence of advanced age and comorbidities, therefore such patients are often not deemed suitable for surgical treatment. Recently, percutaneous valve replacement has emerged as an optional treatment for such patients, particularly for treating severe aortic stenosis and severe mitral regurgitation.
Related Concept Videos
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Heart Failure VI: Adjunct Therapies
Pericarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
